论文部分内容阅读
可溶性白细胞介素2受体(ｓＩＬ2Ｒ)在造血系统肿瘤患者血清中水平的变化与病变活动、治疗效果及预后相关[13]。ＩＬ6是一个具有广泛生物学活性的细胞因子。急性淋巴细胞白血病(ＡＬＬ)患者脑脊液(ＣＳＦ)中ｓＩＬ2Ｒ的变化,国内外已有报道,但同时检测ＣＳＦ中ｓＩＬ2Ｒ和ＩＬ6?
The serum level of soluble interleukin 2 receptor (sIL2R) in patients with hematopoietic system tumors is related to the disease activity, therapeutic effect and prognosis [13]. IL6 is a cytokine with a wide range of biological activities. The changes of sIL2R in cerebrospinal fluid (CSF) in patients with acute lymphoblastic leukemia (ALL) have been reported at home and abroad, but sIL2R and IL6 in CSF were detected simultaneously.